Tübingen brain researchers receive Eva Luise Köhler Forschungspreis für Seltene Erkrankungen 2018

  You are here: News » News » Award for Tuebingen's brain researchers

2018 02 22 Hedrich Klimosch Eva Luise Koehler Forschungspreis 2018 klein

The researchers investigate a rare and severe genetic form of epilepsy. From left: awardee Dr. Ulrike Hedrich-Klimosch and her colleagues Dr. Markus Wolff, Dr. Stephan Lauxmann, Dr. Thomas Wuttke, Prof. Dr. Holger Lerche.

Copyright: Mareike Kardinal | Hertie Institute for Clinical Brain Research (HIH), 2018

 

On February 20, 2018, Dr. Ulrike Hedrich-Klimosch and her colleagues at the Hertie Institute for Clinical Brain Research and the University and the University Hospital Tübingen were awarded with this year’s Eva Luise Köhler Forschungspreis für Seltene Erkrankungen. The research team studies a rare and severe genetic form of epilepsy. The prize money of € 50,000 will serve the development of a drug therapy for affected patients whose disorder is based on a mutation in the KCNA2 gene. Until today, this form of epilepsy cannot be treated with the usual drugs. However, an active pharmaceutical ingredient - that has been approved for a different disorder - showed promising results in individual treatment attempts. It targets specifically potassium channels, which are genetically modified in the patients. The present approach might establish the first drug therapy for those affected, as the scientists report.

 

...more info (in German only)

Questions?     Dr. Mareike Kardinal       07071-29-88800     mareike.kardinal@medizin.uni-tuebingen.de

News

  • Award Ceremony of 2018 Leibniz Prize

    Researcher Bernhard Schölkopf, Director of the Department of Empirical Inference at the Max Planck Institute for Intelligent Systems in Tübingen, received one of this year’s Leibniz Prizes in Berlin.